GW Taps Julie E. Bauman, MD, MPH, Renowned Cancer Clinician and Researcher, to Serve as Director of the GW Cancer Center
The renowned cancer clinician and researcher starts her new position in March 2022.
We are GW Cancer
Research
The GW Cancer Center boasts state-of-the-art research facilities dedicated to cancer discovery through interdisciplinary collaboration with scientists and clinicians throughout GW.
For Patients & Families
We are pleased that you have selected the GW Cancer Center to provide your cancer care and support. The information found here will acquaint you with available information and resources.
Training and Education
The GW Cancer Center provides a comprehensive range of research education and career development programs designed to equip the next generation of scientists and health care providers.
The GW Cancer Center Patient Experience
view all patient stories
Antoinette Brosset
Breast Cancer
My doctors at GW Cancer Center saved my life more than once.
Vincent Jones
Multiple Myeloma
GW has been the best place for me, my family, and my condition.
Mariam Said
Breast Cancer
My family and I are so grateful to my GW team for their care and compassion.
Recent News
view all news
GW Taps Julie E. Bauman, MD, MPH, Renowned Cancer Clinician and Researcher, to Serve as Director of the GW Cancer Center
The renowned cancer clinician and researcher starts her new position in March 2022.
GW Dermatologist Discusses Skin Cancer Awareness and Prevention
Vishal Patel, MD, director of the Cutaneous Oncology Program at the GW Cancer Center and the GW Medical Faculty Associates, breaks down what you need to know about skin cancer, how it is treated, and what you can do to protect yourself now.
GW Colorectal Surgeon Discusses Cancer Prevention and Treatment
Colorectal cancer is the third leading cause for cancer related deaths in the United States, and March is Colorectal Cancer Awareness Month. During this month, we are reminded that receiving regular cancer screening even while you have no signs or symptoms of disease in an important step in...
GW Reaches $3.2M Agreement to Support Development of Cold Plasma Technology
The ongoing corporate research partnership between SEAS Professor Michael Keidar and the biotech company US Patent Innovations, LLC employs engineering and translational molecular sciences to develop new medical devices
HDAC6 Can Control Tumor Growth and Halt Metastasis in Triple-Negative Breast Cancer
WASHINGTON (Aug. 5, 2020) — Genetic modifier HDAC6 was found to control tumor growth and halt metastasis in triple-negative breast cancer in vivo, according to a new study published in the top-tier journal Cancer Research by investigators at the George Washington University (GW) Cancer Center.
GW Researcher Awarded $3.6M to Investigate HIV Antibody Treatments
WASHINGTON (July 16, 2020) – The National Institutes of Health has awarded $3.6 million to ...
What's Happening
Media Releases
View All Media→GW Experts Available to Comment on Breast Cancer Stories
Experts at the George Washington University (GW) School of Medicine and Health Sciences are available to comment on stories around Breast Cancer Awareness Month. Experts are available to comment on “stage 0” breast cancer diagnosis, personalized medicine, survivorship, trends in breast cancer care and treatment, and more.
GW Cancer Center Publication 2020
At the GW Cancer Center, we believe we have a responsibility to work toward health equity. Whether at the patient’s bedside or crunching data in a lab, connection with the communities we serve forms the foundation of everything we do.
That’s why we chose “re:connect” as the theme of this issue — it’s part of our mission to listen, understand, and address many of the problems that are unique to our region so that, ultimately, we see progress against cancer at a population level. Read Full Magazine
